San Sebastián

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• AstraZeneca2 trials

Running trials

• Active, not recruiting

  A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

  NCT06746116· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

  NCT04494425· Phase 3· AstraZeneca· Source